Efficacy and safety of enzalutamide versus bicalutamide for patients with metastatic prostate cancer (TERRAIN): a randomised, double-blind, phase 2 study

Authors: Neal D. Shore, Simon Chowdhury, Arnauld Villers, Laurence Klotz, D. Robert Siemens, De Phung, Steve van Os, Nahla Hasabou, Fong Wang, Suman Bhattacharya, Axel Heidenreich - The Lancet 2016 cited by 283